ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹392 Cr | ₹3,822 Cr | ₹406 Cr | ₹355 Cr | ₹296 Cr |
What is the latest Consolidated Net Profit of ERIS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹392 Cr |
| Mar2024 | ₹3,822 Cr |
| Mar2023 | ₹406 Cr |
| Mar2022 | ₹355 Cr |
| Mar2021 | ₹296 Cr |
How is Consolidated Net Profit of ERIS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹392 Cr | -89.74 | |
| Mar2024 | ₹3,822 Cr | 841.01 | |
| Mar2023 | ₹406 Cr | 14.35 | |
| Mar2022 | ₹355 Cr | 19.78 | |
| Mar2021 | ₹296 Cr | - | |
Compare Consolidated Net Profit of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,138.6 Cr | -1.3% | -5.9% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.3% |
-5.9% |
-25.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses